Table 1 M1 vaccine expressing MC38 neoantigens (see Fig. 2)
From: Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
| Â | Â | WT Peptide | Neoantigen | Â | Â | ||||
|---|---|---|---|---|---|---|---|---|---|
# | Symbol | Seq | H2-Db | H2-Kb | Seq | H2-Db | H2-Kb | DAI | Imm.Resp. |
1 | Wbp7 | SNFHFMCAR | 39,828 | 499 | SNFHFMCAL | 7213 | 10 | > 5 | + |
2 | Hace1 | QINAFLQGF | 44,767 | 1128 | QIYAFLQGF | 37,598 | 39 | > 5 | + |
3 | Hdgfrp2 | KGYPHWPAR | 43,395 | 4131 | KGYPHWPAL | 12,706 | 33 | > 5 | – |
4 | Kpna6 | CTLQFEAAW | 34,408 | 1319 | CTLQFEAAL | 8030 | 42 | > 5 | – |
5 | Aurkaip1 | RTRFLRRKV | 45,504 | 6329 | RTRFLRLKV | 42,713 | 7062 | 1 | – |
6 | Srebf2 | HSFVDSVGF | 33,887 | 3985 | HSFVYSVGF | 38,481 | 135 | > 5 | – |
7 | Mttp | TGYVERSPR | 41,635 | 11,661 | TGYVERSPL | 9548 | 131 | > 5 | – |
8 | Nle1 | MALSTDYAL | 1982 | 1278 | MALSTYYAL | 407 | 46 | > 5 | +/− |
9 | Zbtb24 | SLLEHMSLH | 43,119 | 18,788 | SLLEHMSLL | 7649 | 265 | > 5 | – |
10 | Hnrnpf | GYVVKLRGL | 42,720 | 3065 | SYVVKLRGL | 38,966 | 438 | > 5 | – |